UCB sees 2012 earnings fall on Europe generic hit
(Reuters)
[unable to retrieve full-text content]Reuters - Belgian drugmaker UCB forecast revenue and profit would fall this year as generic competition was expected to halve European sales of its top-selling drug.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.